Suppliers for CAS
1492-18-8
|
Properties | CAS |
1492-18-8 | Formula |
C20H21N7O7Ca | EINECS |
216-082-8 |
|
|
27 Registered suppliers
Aecochem Corp.
P.R.China
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
H&Z Industry Co.,Ltd
P.R.China
Xingrui Industry Co., Limited
P.R.China
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C20H21N7O7.Ca Molecular Weight: 511.51
More details are to be found here
Newstar Chem Enterprise Ltd.
P.R.China
Molecular Formula: C20H21N7O7.Ca Molecular Weight: 511.51
More details are to be found here
Unilong Industry Co.,Ltd
P.R.China
Molecular Formula: C20H21N7O7.Ca Molecular Weight: 511.51
More details are to be found here
Wuhan PharmChem Co., LTD.
P.R.China
EINECS :216-082-8 Molecular formula :C20H21N7O7.Ca
Shandong Ench Chemical Co.,Ltd
P.R.China
EINECS :216-082-8 Molecular formula :C20H21N7O7.Ca
Shandong Minglang Chemical Co., Ltd
P.R.China
EINECS :216-082-8 Molecular formula :C20H21N7O7.Ca
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
EINECS :216-082-8 Molecular formula :C20H21N7O7.Ca
Lori Industry Co., Ltd
P.R.China
EINECS :216-082-8 Molecular formula :C20H21N7O7.Ca
Finetech Industry Limited
P.R.China
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
More details are to be found here
BOC Sciences
USA
Description : leucovorin calcium is an active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs. Leucovorin calcium counteracts the toxic effects of these medications, 'rescuing' the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity. - Molecular Weight :513.52
- Melting Point :240-250ēC
- Purity :> 98%
Molecular Formula : C20H21N7O7.Ca Canonical SMILES : C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.[Ca+2] InChI : InChI=1S/C20H23N7O7.Ca.H2O/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);;1H2/q;+2;/p-2/t12?,13-;;/m0../s1 InChIKey : ANIWFDFELBSPJN-RIWFDJIXSA-L Appearance : Yellow crystalline powder Storage : Store in a tightly closed container. Keep under an argon blanket. Store in a cool, dry, well-ventilated area away from incompatible substances. Refrigerator (approx 4ēC). Store protected from light and air. Synonyms : IST5-002; IST5 002; IST5002; Benzyl-AMP; N6-Benzyladenosine-5'-phosphate; Folinic acid calcium salt; Calcium Folinate
More details are to be found here
Shandong SanYoung Industry Co., Ltd
P.R.China
Description : leucovorin calcium is an active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs. Leucovorin calcium counteracts the toxic effects of these medications, 'rescuing' the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity. - Molecular Weight :513.52
- Melting Point :240-250ēC
- Purity :> 98%
Molecular Formula : C20H21N7O7.Ca Canonical SMILES : C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.[Ca+2] InChI : InChI=1S/C20H23N7O7.Ca.H2O/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);;1H2/q;+2;/p-2/t12?,13-;;/m0../s1 InChIKey : ANIWFDFELBSPJN-RIWFDJIXSA-L Appearance : Yellow crystalline powder Storage : Store in a tightly closed container. Keep under an argon blanket. Store in a cool, dry, well-ventilated area away from incompatible substances. Refrigerator (approx 4ēC). Store protected from light and air. Synonyms : IST5-002; IST5 002; IST5002; Benzyl-AMP; N6-Benzyladenosine-5'-phosphate; Folinic acid calcium salt; Calcium Folinate
More details are to be found here
Ambeed, Inc.
USA
Purity : 95% Smile code : O=C([C@H](CCC([O-])=O)NC(C1=CC=C(C=C1)NCC2CNC(NC(N)=NC3=O)=C3N2C=O)=O)[O-].[Ca+2] MDL Number : MFCD08704249 MolFormula : C20H21CaN7O7 MolWeight : 511.5014 Available in stock : 34.403
More details are to be found here
BLD Pharmatech Ltd
P.R.China
Smile code: O=C([C@H](CCC([O-])=O)NC(C1=CC=C(C=C1)NCC2CNC(NC(N)=NC3=O)=C3N2C=O)=O)[O-].[Ca+2] MDL Number: MFCD08704249 Purity : 95% Available in stock: 43.776 g
More details are to be found here
Xiamen Equation Chemical Co.,Ltd
P.R.China
Smile code: O=C([C@H](CCC([O-])=O)NC(C1=CC=C(C=C1)NCC2CNC(NC(N)=NC3=O)=C3N2C=O)=O)[O-].[Ca+2] MDL Number: MFCD08704249 Purity : 95% Available in stock: 43.776 g
More details are to be found here
AK Scientific, Inc.
USA
Smile code: O=C([C@H](CCC([O-])=O)NC(C1=CC=C(C=C1)NCC2CNC(NC(N)=NC3=O)=C3N2C=O)=O)[O-].[Ca+2] MDL Number: MFCD08704249 Purity : 95% Available in stock: 43.776 g
More details are to be found here
Chemlyte Solutions
P.R.China
More details are to be found here
Chemos GmbH & Co. KG
Germany
More details are to be found here
BuGuCh & Partners
Germany
Appearance:White or light yellow, amorphous or crystalline powder Content: 97.0% ~ 102.0% Use: one kind folic acid antidote, API Peculiarity:Medicine Grade Packing: 1kg/bag or 25kgs/drum Min.Order Quantity:100g Grade Standard:Medicine Grade Product Specifications: 1.PH:6.0-8.0 2.Heavy metals:NMT 0.005% 3.Water Content:NMT 17.0% 4.Calcium:7.54%~8.14% 5.Standard: USP31 Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time following methotrexate as part of a total chemotherapeutic plan, where it may `rescue` bone marrow and gastrointestinal mucosa cells from methotrexate. There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
Appearance:White or light yellow, amorphous or crystalline powder Content: 97.0% ~ 102.0% Use: one kind folic acid antidote, API Peculiarity:Medicine Grade Packing: 1kg/bag or 25kgs/drum Min.Order Quantity:100g Grade Standard:Medicine Grade Product Specifications: 1.PH:6.0-8.0 2.Heavy metals:NMT 0.005% 3.Water Content:NMT 17.0% 4.Calcium:7.54%~8.14% 5.Standard: USP31 Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time following methotrexate as part of a total chemotherapeutic plan, where it may `rescue` bone marrow and gastrointestinal mucosa cells from methotrexate. There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
Appearance:White or light yellow, amorphous or crystalline powder Content: 97.0% ~ 102.0% Use: one kind folic acid antidote, API Peculiarity:Medicine Grade Packing: 1kg/bag or 25kgs/drum Min.Order Quantity:100g Grade Standard:Medicine Grade Product Specifications: 1.PH:6.0-8.0 2.Heavy metals:NMT 0.005% 3.Water Content:NMT 17.0% 4.Calcium:7.54%~8.14% 5.Standard: USP31 Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time following methotrexate as part of a total chemotherapeutic plan, where it may `rescue` bone marrow and gastrointestinal mucosa cells from methotrexate. There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
Appearance:White or light yellow, amorphous or crystalline powder
Content: 97.0% ~ 102.0%
Use: one kind folic acid antidote, API
Peculiarity:Medicine Grade
Packing: 1kg/bag or 25kgs/drum
Min.Order Quantity:100g
Grade Standard:Medicine Grade
Product Specifications:
1.PH:6.0-8.0
2.Heavy metals:NMT 0.005%
3.Water Content:NMT 17.0%
4.Calcium:7.54%~8.14%
5.Standard: USP31
Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time
following methotrexate as part of a total chemotherapeutic plan, where it may `rescue`
bone marrow and gastrointestinal mucosa cells from methotrexate.
There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
Cerbios-Pharma SA
Switzerland
Appearance:White or light yellow, amorphous or crystalline powder
Content: 97.0% ~ 102.0%
Use: one kind folic acid antidote, API
Peculiarity:Medicine Grade
Packing: 1kg/bag or 25kgs/drum
Min.Order Quantity:100g
Grade Standard:Medicine Grade
Product Specifications:
1.PH:6.0-8.0
2.Heavy metals:NMT 0.005%
3.Water Content:NMT 17.0%
4.Calcium:7.54%~8.14%
5.Standard: USP31
Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time
following methotrexate as part of a total chemotherapeutic plan, where it may `rescue`
bone marrow and gastrointestinal mucosa cells from methotrexate.
There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
Sigma-Aldrich International GmbH
Switzerland
Appearance:White or light yellow, amorphous or crystalline powder
Content: 97.0% ~ 102.0%
Use: one kind folic acid antidote, API
Peculiarity:Medicine Grade
Packing: 1kg/bag or 25kgs/drum
Min.Order Quantity:100g
Grade Standard:Medicine Grade
Product Specifications:
1.PH:6.0-8.0
2.Heavy metals:NMT 0.005%
3.Water Content:NMT 17.0%
4.Calcium:7.54%~8.14%
5.Standard: USP31
Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time
following methotrexate as part of a total chemotherapeutic plan, where it may `rescue`
bone marrow and gastrointestinal mucosa cells from methotrexate.
There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
Santa Cruz Biotechnology, Inc.
USA
Appearance:White or light yellow, amorphous or crystalline powder
Content: 97.0% ~ 102.0%
Use: one kind folic acid antidote, API
Peculiarity:Medicine Grade
Packing: 1kg/bag or 25kgs/drum
Min.Order Quantity:100g
Grade Standard:Medicine Grade
Product Specifications:
1.PH:6.0-8.0
2.Heavy metals:NMT 0.005%
3.Water Content:NMT 17.0%
4.Calcium:7.54%~8.14%
5.Standard: USP31
Calcium folinate/leucovorin calcium/Folinic acid is administered at the appropriate time
following methotrexate as part of a total chemotherapeutic plan, where it may `rescue`
bone marrow and gastrointestinal mucosa cells from methotrexate.
There is no apparent effect on preexisting methotrexate-induced nephrotoxicity.
|